Here, Gregory Martin, MD, medical director of the Orthopedics Institute at JFK Medical Center in Florida, discusses the technology and where it's headed in the future.
Q: How have anatomic knee replacements changed over the past few years?
Dr. Gregory Martin: ConforMIS was founded in 2004 and introduced the first of its knee replacements, a partial knee replacement system, in the late 2000s. The interesting thing is they are able to change the technology very quickly and respond to feedback more than the traditional implant company. So the systems they introduced back then have already gone to a second generation, what they call G2, version.
More recently, the iTotal was FDA-cleared at the beginning of last year and was on limited release over the past 18 months. Over that time they have incorporated beneficial changes to the implants and instrumentation and preoperative plan quality in the iView, the personalized planning images that make it simple to visualize joint preparation during surgery. Just a few months ago, they formally launched the G2 version of that system which is just unheard of in orthopedics to go to a second generation in less than two years.
Because of their delivery model, ConforMIS could implement feedback right away. With traditional implants, a company sends out thousands of implants, instrumentation and inventory. If they are going to revise something, it's a huge under taking and something that happens over several years, not 18 months. As we develop the patient-specific implants and the techniques of putting them in, there will always be changes and refinements in surgical technique.
Q: What is unique about the iTotal G2?
GM: Unique is a term perfect to describe the iTotal. It is the only patient-specific implant of its kind on the market — other companies have patient-specific guides, but they are designed to help put in off-the-shelf implants. Both the implant and instrumentation for the iTotal G2 are patient-specific. As we see other implant companies release new implant platforms, they are increasing the number of sizes they offer to fit more patients, but they are not customizing the fit or shape to each individual. We are seeing other companies talk about single-use disposable instrumentation, like ConforMIS, so it's already making an impact on the market.
Q: What are the advantages of this technology?
GM: I think the technology has advantages for all the different players involved. All the stakeholders have benefits as a result of the technology. From the physician's perspective, it's a quick, efficient and refined technique. It inspires confidence as you do it because the instrumentation fits well and design fits well. It doesn't leave any doubt that you are doing it right.
Since the implant fits anatomically, they don't have to make the traditional compromises to fit the knees. It's reassuring for the surgeon. For the patient, the intraoperative advantages are realized because you see a lot less blood loss and swelling. It's pretty dramatic even intraoperatively because they aren't losing blood like in traditional knee replacements. That translates into an earlier return to function. The length of stay at the hospital for my patients has decreased by a day.
Q: How will this technology impact the future of orthopedic surgery?
GM: I think ultimately the delivery model makes the most sense from a technology standpoint because it doesn't make sense to have nine or 10 different trays prepared for every surgery. We are asked to do more surgeries for less reimbursement, so efficiency is important. I think the whole set up is a much easier process from a logistics standpoint.
In addition, I think the single-use instrumentation is important. There has been a major Wall Street Journal report on how the re-sterilization process in hospitals can be contaminated. It just makes sense to have single-use instrumentation for patients; it eliminates one variable that can be a potential source of infection. I think that this is just the start of patient-specific orthopedics. Other fields like dentistry have been doing patient-specific for a long period of time.
Q: Do you see the trend of patient-specific implants in orthopedics continuing in the future?
GM: I think we are going to see this trend continue in medicine because it makes sense to the doctor and patient. Patients get it instantly and size to them is a big issue. They may not have the medical knowledge to know the details but it intuitively makes sense. We are going to see this trend in other prosthetics being made individually as well.
Ten years ago, it was logistically very difficult to produce patient-specific implants, but the ConforMIS headquarters is extremely impressive. It's interesting to see how the manufacturing technology has adapted to allow the company to do this in an efficient manner.
More Articles on Orthopedic Devices:
15 Orthopedic Device Company Financial Reports
12 Orthopedic Surgeries for Professional Athletes
10 Key Trends in Spine Surgery for 2013
Patient-Specific Implants — the Future for Orthopedics: Q&A With Dr. Greg Martin of JFK Medical Center FeaturedWritten by Laura Dyrda | Tuesday, 13 November 2012 14:30
Orthopedic device makers are focusing more on the biological differences in patients and producing more anatomically correct options than in the past. However, ConforMIS has been refining its patient-specific process for partial and total knee replacements where individual cutting guides, instrumentation and implants are constructed for every procedure. The one-time use materials arrive at the operating room already sterilized and ready for surgery.
© Copyright ASC COMMUNICATIONS 2015. Interested in LINKING to or REPRINTING this content? View our policies here.
Most Read - Devices & Implants
- J&J subsidiaries slammed with lawsuit related to hip replacement product failure: 7 key notes
- 5 recent spine, orthopedic device company mergers & acquisitions
- K2M, InVivo Therapeutics, Zimmer & more — 19 key notes
- Stryker recalls 16k+ units of orthopedic products: 5 takeaways
- FTC final order preserves competition: 5 things to know about Zimmer's acquisition of Biomet
Top 40 Articles from the Past 6 Months
- 12 statistics on neurosurgeon salary in 2015
- North American Spine brings in two new procedures — 5 things to know
- Drs. Larry Lenke, Daniel Riew, Ronald Lehman leaving St. Louis for NYC — 5 things to know
- DePuy Synthes, Stryker, Zimmer, Medtronic lead global orthopedics now — 8 key notes on where they're headed
- Bundled spine surgery for Walmart, Lowe's employees — 6 things to know
- Medtronic is headed for strong 2015 — 8 reasons why
- 20 Spine Surgeon Leadership Awards | 2015
- 25 Spine Device Awards | 2015
- 15 things to know about Zimmer Biomet
- Neurosurgeon named in counterfeit spinal implant lawsuit — 5 things to know
- 10 spine, orthopedic surgeon tech entrepreneurs to know
- A differentiated approach in lateral spine surgery: Oblique lateral interbody fusion (OLIF at L2-L5)
- Top 10 specialties with highest pay — Orthopedists lead the pack
- Zimmer voluntarily recalls knee device
- Safeguards to Prevent Neurologic Complications after Epidural Steroid Injections: Analysis of Evidence and Lack of Applicability of Controversial Policies
- 6 spine physicians ranked #1 on Google
- Dr. Aria Sabit pleads guilty to unnecessary spine surgery, faces 11+ years in prison — 5 things to know
- Northwestern's Feinberg School of Medicine neurological surgery chief Dr. Andrew Parsa dies
- Is the Zimmer-Biomet closed merger finally around the corner? 5 things to know
- Dr. Neal ElAttrache to perform Manny Pacquiao's shoulder surgery: 5 things to know
- Spinal fusion vs. disc replacement: Which costs more? 5 key notes
- Another spine surgeon named in "fake implants" lawsuit — This time in Maryland: 5 key notes
- Medtronic pays 8 physicians $1M+: 5 key notes
- Building an empire: How Dr. Douglas Won created a physician-led health system
- Dr. Sanjay Khurana helps rescue Harrison Ford from crashed air plane
- Zimmer Q1 sales drop 2.3%, Biomet merger still not final — 10 things to know
- How The CORE Institute grew 40% last quarter — IT leads the way
- 55 statistics and issues for neurosurgeons and orthopedic spine surgeons — compensation, global device market and more
- UPMC's Dr. Tanya Hagen dies at age 45
- Is Smith & Nephew's cost-conscious strategy working? 5 key notes
- Hospitals face 4 lawsuits in connection with unnecessary spine surgeries case — 6 things to know
- Johnson & Johnson (J&J) sells Cordis line for $1.9B: What it could mean for DePuy Synthes
- How high-energy spine surgeons start their day — 5 things to know
- Spinal deformity surgery — On the cutting edge with Drs. Isador Lieberman, Suken Shah
- Dr. Ziya Gokaslan to leave Johns Hopkins for Rhode Island Hospital
- Cervical disc replacement Mobi-C vs. spinal fusion: Are there advantages to one? 6 key notes
- Medtronic facing product liability lawsuit over Infuse once more: 9 things to know
- Hospital for Special Surgery names Dr. Frank Schwab spine service chief — 5 things to know
- 5 statistics on orthopedic surgeon net worth
- Patient sues troubled orthopedic surgeon for malpractice — 7 things to know